TDI-11861

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 130159

CAS#: 2857049-72-8

Description: TDI-11861 is a sAC/ADCY10 inhibitor and has promise for use as a male contraceptive, which is partially attributed to its slow dissociation rates. TDI-11861 has been shown to inhibit sperm motility in vivo. TDI-11861 functions by binding sAC protein and inhibiting the in vitro activity of adenylyl cyclase activity of purified sAC protein.

Chemical Structure

img
TDI-11861
CAS# 2857049-72-8
Instruction

Theoretical Analysis

MedKoo Cat#: 130159
Name: TDI-11861
CAS#: 2857049-72-8
Chemical Formula: C22H25ClF2N6O3
Exact Mass: 494.16
Molecular Weight: 494.930
Elemental Analysis: C, 53.39; H, 5.09; Cl, 7.16; F, 7.68; N, 16.98; O, 9.70

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: TDI-11861; TDI11861; TDI 11861

IUPAC/Chemical Name: (R)-(4-(2-(2-((3-(2-amino-6-chloropyrimidin-4-yl)-1-(difluoromethyl)-1H-pyrazol-4-yl)methyl)phenoxy)ethyl)morpholin-3-yl)methanol

InChi Key: XVGSKZXXLKUEIO-MRXNPFEDSA-N

InChi Code: InChI=1S/C22H25ClF2N6O3/c23-19-10-17(27-22(26)28-19)20-15(11-31(29-20)21(24)25)9-14-3-1-2-4-18(14)34-8-6-30-5-7-33-13-16(30)12-32/h1-4,10-11,16,21,32H,5-9,12-13H2,(H2,26,27,28)/t16-/m1/s1

SMILES Code: OC[C@H]1N(CCOC2=CC=CC=C2CC3=CN(C(F)F)N=C3C4=NC(N)=NC(Cl)=C4)CCOC1

Appearance: To be determined

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 494.93 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1. Balbach M, Rossetti T, Ferreira J, Ghanem L, Ritagliati C, Myers RW, Huggins DJ, Steegborn C, Miranda IC, Meinke PT, Buck J, Levin LR. On-demand male contraception via acute inhibition of soluble adenylyl cyclase. Nat Commun. 2023 Feb 14;14(1):637. doi: 10.1038/s41467-023-36119-6. PMID: 36788210; PMCID: PMC9929232.

2. Rossetti T, Ferreira J, Ghanem L, Buck H, Steegborn C, Myers RW, Meinke PT, Levin LR, Buck J. Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential. Front Physiol. 2022 Sep 28;13:1013845. doi: 10.3389/fphys.2022.1013845. Erratum in: Front Physiol. 2022 Nov 21;13:1092217. PMID: 36246105; PMCID: PMC9554468.